CAS 1333390-56-9

1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea

CAS: 1333390-56-9

Formula: C₁₄H₉ClF₄N₂O₂

Purezza: 98%

Peso molecolare: 348.6801

Ref: IN-DA01KGET

1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea

CAS: 1333390-56-9

1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea

Purezza: 98%

Peso molecolare: 348.68g/mol

Ref: 54-PC1008097

1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea

CAS: 1333390-56-9

Purezza: 98%

Peso molecolare: 348.6799927

Ref: 10-F789914

1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea

CAS: 1333390-56-9

Regorafenib is a multikinase inhibitor that inhibits the activity of kinases in the RAS-RAF-MEK-ERK pathway, which are enzymes that regulate cell proliferation. It is an oral drug used to treat patients with metastatic colorectal cancer who have been previously treated with chemotherapy. The target of regorafenib is the oncogenic kinases in the RAS-RAF-MEK-ERK pathway, which are important for tumor growth and progression. Regorafenib has shown efficacy against many different types of cancers, including colorectal, thyroid, lung and renal cancers.

Formula: C₁₄H₉ClF₄N₂O₂

Purezza: Min. 95%

Peso molecolare: 348.68 g/mol

Ref: 3D-IDC39056